Skip to main content
. 2012 Jul 31;62(1):125–135. doi: 10.1007/s00262-012-1319-0

Fig. 5.

Fig. 5

a Kaplan–Meier estimates of progression-free survival for newly diagnosed patients (n = 16). Dotted lines illustrate the 95 % confidence intervals, and hash marks denote censored patients. b Kaplan–Meier estimates of overall survival for newly diagnosed patients (n = 16). Dotted lines illustrate the 95 % confidence intervals, and hash marks denote censored patients